{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T21:59:37Z","timestamp":1786831177983,"version":"build-2736575974"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Sci Pollut Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s11356-021-18429-8","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T10:02:54Z","timestamp":1645610574000},"page":"32605-32630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting therapeutic approaches and highlighting the potential role of nanotechnology in atopic dermatitis"],"prefix":"10.1007","volume":"29","author":[{"given":"Sukhbir","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishrat","family":"Zahoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridevi","family":"Chigurupati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Rachamalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aayush","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Naved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Pritima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syam","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotfi","family":"Aleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bungau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"18429_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/all.13320","volume":"73","author":"K Abuabara","year":"2018","unstructured":"Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM (2018) The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 73:696\u2013704. https:\/\/doi.org\/10.1111\/all.13320","journal-title":"Allergy"},{"key":"18429_CR2","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s40265-017-0784-3","volume":"77","author":"J Ahluwalia","year":"2017","unstructured":"Ahluwalia J, Udkoff J, Waldman A, Borok J, Eichenfield LF (2017) Phosphodiesterase 4 inhibitor therapies for atopic dermatitis: progress and outlook. Drugs 77:1389\u20131397. https:\/\/doi.org\/10.1007\/s40265-017-0784-3","journal-title":"Drugs"},{"key":"18429_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","volume":"118","author":"CA Akdis","year":"2006","unstructured":"Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report. J Allergy Clin Immunol 118:152\u2013169. https:\/\/doi.org\/10.1016\/j.jaci.2006.03.045","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/MPG.0b013e3181cea52b","volume":"50","author":"DD Alexander","year":"2010","unstructured":"Alexander DD, Cabana MD (2010) Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr 50:422\u2013430. https:\/\/doi.org\/10.1097\/MPG.0b013e3181cea52b","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"18429_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MOP.0b013e32832130a9","volume":"21","author":"PC Anderson","year":"2007","unstructured":"Anderson PC, Dinulos JG (2007) Atopic dermatitis and alternative management strategies. Curr Opin Pediatr 21:131\u2013138. https:\/\/doi.org\/10.1097\/MOP.0b013e32832130a9","journal-title":"Curr Opin Pediatr"},{"key":"18429_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaip.2012.09.002","volume":"1","author":"PD Arkwright","year":"2013","unstructured":"Arkwright PD, Motala C, Subramanian H, Spergel J, Schneider LC, Wollenberg A (2013) Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract 1:142\u2013151. https:\/\/doi.org\/10.1016\/j.jaip.2012.09.002","journal-title":"J Allergy Clin Immunol Pract"},{"key":"18429_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","volume":"330","author":"DM Ashcroft","year":"2005","unstructured":"Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC (2005) Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 330:516. https:\/\/doi.org\/10.1136\/bmj.38376.439653.D3","journal-title":"BMJ"},{"key":"18429_CR8","doi-asserted-by":"publisher","unstructured":"Ashcroft DM, Chen LC, Garside R, Stein K, Williams HC (2007) Topical pimecrolimus for eczema. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005500.pub2","DOI":"10.1002\/14651858.CD005500.pub2"},{"key":"18429_CR9","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/bmj.327.7421.942","volume":"327","author":"DJ Atherton","year":"2003","unstructured":"Atherton DJ (2003) Topical corticosteroids in atopic dermatitis. BMJ 327:942\u2013943. https:\/\/doi.org\/10.1136\/bmj.327.7421.942","journal-title":"BMJ"},{"key":"18429_CR10","unstructured":"Arvind Kumar Bansal, Prashant kumar Khodabhai Parma. (2020) Nanocrystals based formulations for improved topical delivery of apremilast. IN201911003539."},{"key":"18429_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ajd.12015","volume":"54","author":"TM Barnes","year":"2013","unstructured":"Barnes TM, Greive KA (2013) Use of bleach baths for the treatment of infected atopic eczema. Australas J Dermatol 54:251\u2013258. https:\/\/doi.org\/10.1111\/ajd.12015","journal-title":"Australas J Dermatol"},{"key":"18429_CR12","first-page":"321","volume":"150","author":"FA Belloni","year":"2015","unstructured":"Belloni FA, Neri L (2015) Antibiotic therapy in the management of atopic dermatitis. G Ital Dermatol Venereol 150:321\u2013325","journal-title":"G Ital Dermatol Venereol"},{"key":"18429_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jaad.2006.01.054","volume":"54","author":"TG Berger","year":"2006","unstructured":"Berger TG, Duvic M, Van Voorhees AS, Frieden IJ (2006) The use of topical calcineurin inhibitors in dermatology: safety concerns: report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 54:818\u2013823. https:\/\/doi.org\/10.1016\/j.jaad.2006.01.054","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaip.2012.11.005","volume":"1","author":"MM Bergmann","year":"2013","unstructured":"Bergmann MM, Caubet JC, Boguniewicz M, Eigenmann PA (2013) Evaluation of food allergy in patients with atopic dermatitis. J Allergy Clin Immunol Pract 1:22\u201328. https:\/\/doi.org\/10.1016\/j.jaip.2012.11.005","journal-title":"J Allergy Clin Immunol Pract"},{"key":"18429_CR15","first-page":"35","volume":"86","author":"R Berke","year":"2012","unstructured":"Berke R, Singh A, Guralnick M (2012) Atopic dermatitis: an overview. Am Fam Physician 86:35\u201342","journal-title":"Am Fam Physician"},{"key":"18429_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/bmj.326.7403.1367","volume":"326","author":"J Berth-Jones","year":"2003","unstructured":"Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA (2003) Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 326:1367. https:\/\/doi.org\/10.1136\/bmj.326.7403.1367","journal-title":"BMJ"},{"key":"18429_CR17","unstructured":"Karel Bezouska, Jan Engl, Lubomir Janda, Adam Norek. (2020) Combined multistage microbial preparations and method of their application. US20200254030."},{"key":"18429_CR18","unstructured":"Karel Bezouska, Jan Engl, Lubomir Janda, Adam Norek. (2020) Combined multistage microbial preparations and method of their application. EP3692980."},{"key":"18429_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/08982104.2013.843192","volume":"24","author":"ML Bikkad","year":"2014","unstructured":"Bikkad ML, Nathani AH, Mandlik SK, Shrotriya SN, Ranpise NS (2014) Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery. J Liposome Res 24:113\u2013123. https:\/\/doi.org\/10.3109\/08982104.2013.843192","journal-title":"J Liposome Res"},{"key":"18429_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.5114\/ada.2017.72461","volume":"34","author":"I B\u0142a\u017cewicz","year":"2017","unstructured":"B\u0142a\u017cewicz I, Ja\u015bkiewicz M, Bauer M, Piechowicz L, Nowicki RJ, Kamysz W, Bara\u0144ska-Rybak W (2017) Decolonization of Staphylococcus aureus in patients with atopic dermatitis: a reason for increasing resistance to antibiotics? Postepy Dermatol Alergol 34:553. https:\/\/doi.org\/10.5114\/ada.2017.72461","journal-title":"Postepy Dermatol Alergol"},{"key":"18429_CR21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jaip.2017.08.005","volume":"5","author":"M Boguniewicz","year":"2017","unstructured":"Boguniewicz M, Alexis AF, Beck LA, Block J, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Lebwohl M (2017) Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies. J Allergy Clin Immunol Pract 5:1519\u20131531. https:\/\/doi.org\/10.1016\/j.jaip.2017.08.005","journal-title":"J Allergy Clin Immunol Pract"},{"key":"18429_CR22","first-page":"832","volume":"5","author":"C Bouton","year":"2009","unstructured":"Bouton C, Ducommun J (2009) House dust mite allergy: myths and realities. Rev Med Suisse 5:832\u2013836","journal-title":"Rev Med Suisse"},{"key":"18429_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaip.2018.10.021","volume":"7","author":"KK Brar","year":"2019","unstructured":"Brar KK, Nicol NH, Boguniewicz M (2019) Strategies for successful management of severe atopic dermatitis. J Allergy Clin Immunol Pract 7:1\u20136. https:\/\/doi.org\/10.1016\/j.jaip.2018.10.021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"18429_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1365-2133.2007.08412.x","volume":"158","author":"EE Brenninkmeijer","year":"2008","unstructured":"Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI (2008) Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 158:754\u2013765. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08412.x","journal-title":"Br J Dermatol"},{"key":"18429_CR25","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1034\/j.1398-9995.2001.00146.x","volume":"56","author":"K Breuer","year":"2001","unstructured":"Breuer K, Kapp A, Werfel T (2001) Bacterial infections and atopic dermatitis. Allergy 56:1034\u20131041. https:\/\/doi.org\/10.1034\/j.1398-9995.2001.00146.x","journal-title":"Allergy"},{"key":"18429_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jaad.2016.02.1228","volume":"75","author":"JA Broeders","year":"2016","unstructured":"Broeders JA, Ali UA, Fischer G (2016) Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: a 15-year experience. J Am Acad Dermatol 75:410\u2013419. https:\/\/doi.org\/10.1016\/j.jaad.2016.02.1228","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jaci.2014.08.011","volume":"134","author":"HA Brough","year":"2014","unstructured":"Brough HA, Simpson A, Makinson K, Hankinson J, Brown S, Douiri A, Belgrave DC, Penagos M, Stephens AC, McLean WI, Turcanu V (2014) Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol 134:867\u2013875. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.011","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2340\/00015555-3513","volume":"100","author":"SJ Brown","year":"2020","unstructured":"Brown SJ, Elias MS, Bradley M (2020) Genetics in atopic dermatitis: historical perspective and future prospects. Acta Derm Venereol 100:349\u2013357. https:\/\/doi.org\/10.2340\/00015555-3513","journal-title":"Acta Derm Venereol"},{"key":"18429_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1610-0387.2011.07656.x","volume":"9","author":"C Bussmann","year":"2011","unstructured":"Bussmann C, Weidinger S, Novak N (2011) Genetics of atopic dermatitis. J Dtsch Dermatol Ges 9:670\u2013676. https:\/\/doi.org\/10.1111\/j.1610-0387.2011.07656.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"18429_CR30","first-page":"523","volume":"75","author":"LM Buys","year":"2007","unstructured":"Buys LM (2007) Treatment options for atopic dermatitis. Am Fam Physician 75:523\u2013528","journal-title":"Am Fam Physician"},{"key":"18429_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.05.002","volume":"42","author":"B Cabanillas","year":"2016","unstructured":"Cabanillas B, Novak N (2016) Atopic dermatitis and filaggrin. Curr Opin Immunol 42:1\u20138. https:\/\/doi.org\/10.1016\/j.coi.2016.05.002","journal-title":"Curr Opin Immunol"},{"key":"18429_CR32","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1021\/acsapm.1c00021","volume":"3","author":"EV Campos","year":"2021","unstructured":"Campos EV, Proen\u00e7a PL, Costa TG, de Lima R, Hedtrich S, Fraceto LF, de Araujo DR (2021) Hydrogels containing budesonide-loaded nanoparticles to facilitate percutaneous absorption for atopic dermatitis treatment applications. ACS Appl Polym Mater 3:4436\u20134449. https:\/\/doi.org\/10.1021\/acsapm.1c00021","journal-title":"ACS Appl Polym Mater"},{"key":"18429_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","volume":"133","author":"F Cevikbas","year":"2014","unstructured":"Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, Kukova G, Buhl T, Ikoma A, Buddenkotte J, Soumelis V (2014) A sensory neuron\u2013expressed IL-31 receptor mediates T helper cell\u2013dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 133:448\u2013460. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.048","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR34","unstructured":"Wang CY\u00a0(2020) Peptide immunogens of IL-31 and formulations thereof for the treatment and\/or prevention of atopic dermatitis. EP3724218."},{"key":"18429_CR35","unstructured":"Wang CY\u00a0\u00a0(2021) Peptide immunogens of IL-31 and formulations thereof for the treatment and\/or prevention of atopic dermatitis. US20210079054."},{"key":"18429_CR36","unstructured":"Charles, Rodney, Greenaway, Evans, Cameron, Robert, Stevenson, Marc, Barry, Brown. (2020) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. US20200390689."},{"key":"18429_CR37","unstructured":"Charles, Rodney, Greenaway, Evans, Cameron, Robert, Stevenson, Marc, Barry, Brown. (2020) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. EP3737354"},{"key":"18429_CR38","unstructured":"Charles, Rodney, Greenaway, Evans, Cameron, Robert, Stevenson, Marc, Barry, Brown. (2020) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. CN111818910."},{"key":"18429_CR39","unstructured":"Charles, Rodney, Greenaway, Evans, Cameron, Robert, Stevenson, Marc, Barry, Brown. (2020) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. NZ765501."},{"key":"18429_CR40","unstructured":"Charles, Rodney, Greenaway, Evans, Cameron, Robert, Stevenson, Marc, Barry, Brown. (2020) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. SG11202005781W."},{"key":"18429_CR41","unstructured":"Charles, Rodney, Greenaway, Evans, Cameron, Robert, Stevenson, Marc, Barry, Brown. Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof. IN202017032069."},{"key":"18429_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5021\/ad.2010.22.2.180","volume":"22","author":"S Cho","year":"2010","unstructured":"Cho S, Kim HJ, Oh SH, Park CO, Jung JY, Lee KH (2010) The influence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann Dermatol 22:180\u2013185. https:\/\/doi.org\/10.5021\/ad.2010.22.2.180","journal-title":"Ann Dermatol"},{"key":"18429_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/children6100108","volume":"6","author":"R Chovatiya","year":"2019","unstructured":"Chovatiya R, Silverberg JI (2019) Pathophysiology of atopic dermatitis and psoriasis: implications for management in children. Children 6:108. https:\/\/doi.org\/10.3390\/children6100108","journal-title":"Children"},{"key":"18429_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","volume":"65","author":"MK Church","year":"2010","unstructured":"Church MK, Maurer M, Simons FE, Bindslev-Jensen C, Van Cauwenberge P, Bousquet J, Holgate ST, Zuberbier T (2010) Risk of first-generation H1-antihistamines: a GA2LEN position paper. Allergy 65:459\u2013466. https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02325.x","journal-title":"Allergy"},{"key":"18429_CR45","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jid.2009.133","volume":"129","author":"MJ Cork","year":"2009","unstructured":"Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, MacGowan AL, Tazi-Ahnini R, Ward SJ (2009) Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 129:1892\u20131908. https:\/\/doi.org\/10.1038\/jid.2009.133","journal-title":"J Invest Dermatol"},{"key":"18429_CR46","unstructured":"Cunningham, Nicholas Finn, Singh, Paramjit, Panda, Debendra, Kumar, Badhan, Atul, Chhagan, Price, Jeffrey Ellis. (2021) Palatable formulations. NZ779157."},{"key":"18429_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.12932\/AP0732.34.2.2016","volume":"34","author":"E D'Auria","year":"2016","unstructured":"D\u2019Auria E, Banderali G, Barberi S, Gualandri L, Pietra B, Riva E, Cerri A (2016) Atopic dermatitis: recent insight on pathogenesis and novel therapeutic target Asian Pac. J Allergy Immunol 34:98\u2013108. https:\/\/doi.org\/10.12932\/AP0732.34.2.2016","journal-title":"J Allergy Immunol"},{"key":"18429_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/ACI.0b013e3283551da5","volume":"12","author":"KS Denby","year":"2012","unstructured":"Denby KS, Beck LA (2012) Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol 12:421\u2013426. https:\/\/doi.org\/10.1097\/ACI.0b013e3283551da5","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"18429_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12098-017-2535-6","volume":"85","author":"JM Devdas","year":"2018","unstructured":"Devdas JM, Mckie C, Fox AT, Ratageri VH (2018) Food allergy in children: an overview. Indian J Pediatr 85:369\u2013374. https:\/\/doi.org\/10.1007\/s12098-017-2535-6","journal-title":"Indian J Pediatr"},{"key":"18429_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1365-2133.2006.07157.x","volume":"154","author":"AC Devillers","year":"2006","unstructured":"Devillers AC, Oranje A (2006) Efficacy and safety of \u2018wet-wrap\u2019dressings as an intervention treatment in children with severe and\/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol 154:579\u2013585. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07157.x","journal-title":"Br J Dermatol"},{"key":"18429_CR51","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4103\/0378-6323.69066","volume":"76","author":"S Dhar","year":"2010","unstructured":"Dhar S, Banerjee R (2010) Atopic dermatitis in infants and children in India. Indian J Dermatol Venereol Leprol 76:504. https:\/\/doi.org\/10.4103\/0378-6323.69066","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"18429_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/all.12268","volume":"69","author":"SC Dharmage","year":"2014","unstructured":"Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ (2014) Atopic dermatitis and the atopic march revisited. Allergy 69:17\u201327. https:\/\/doi.org\/10.1111\/all.12268","journal-title":"Allergy"},{"key":"18429_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.anai.2017.11.009","volume":"120","author":"C Dinakar","year":"2018","unstructured":"Dinakar C, Fineman SM, Tilles SA (2018) Recent advances in atopic dermatitis. Ann Allergy Asthma Immunol 120:8\u20139. https:\/\/doi.org\/10.1016\/j.anai.2017.11.009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"18429_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","volume":"71","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM (2014) Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 71:116\u2013132. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.023","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR55","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/exd.13693","volume":"27","author":"PM Elias","year":"2018","unstructured":"Elias PM (2018) Primary role of barrier dysfunction in the pathogenesis of atopic dermatitis. Exp Dermatol 27:847\u2013851. https:\/\/doi.org\/10.1111\/exd.13693","journal-title":"Exp Dermatol"},{"key":"18429_CR56","unstructured":"Elliott, Russell, Hazot, Yohan, Winckle, Gareth, Margulis, Ariel. (2021) Topical composition comprising tofacitinib and fingolimod. WO2021138525."},{"key":"18429_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jdv.13301","volume":"30","author":"KA Engebretsen","year":"2016","unstructured":"Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP (2016) The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol 30:223\u2013249. https:\/\/doi.org\/10.1111\/jdv.13301","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"18429_CR58","doi-asserted-by":"publisher","first-page":"e1005076","DOI":"10.1371\/journal.pgen.1005076","volume":"11","author":"J Esparza-Gordillo","year":"2015","unstructured":"Esparza-Gordillo J, Matanovic A, Marenholz I, Bauerfeind A, Rohde K, Nemat K, Lee-Kirsch MA, Nordenskj\u00f6ld M, Winge MC, Keil T, Kr\u00fcger R (2015) Maternal filaggrin mutations increase the risk of atopic dermatitis in children: an effect independent of mutation inheritance. PLoS Genet 11:e1005076. https:\/\/doi.org\/10.1371\/journal.pgen.1005076","journal-title":"PLoS Genet"},{"key":"18429_CR59","doi-asserted-by":"publisher","first-page":"VS4","DOI":"10.1016\/S0151-9638(18)30085-1","volume":"144","author":"K Ezzedine","year":"2017","unstructured":"Ezzedine K, Kechichian E (2017) Epidemiology of atopic dermatitis. Ann Dermatol Venereol 144:VS4\u2013VS7. https:\/\/doi.org\/10.1016\/S0151-9638(18)30085-1","journal-title":"Ann Dermatol Venereol"},{"key":"18429_CR60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1128\/CMR.15.4.545-563.2002","volume":"15","author":"J Faergemann","year":"2002","unstructured":"Faergemann J (2002) Atopic dermatitis and fungi. Clin Microbiol Rev 15:545\u2013563. https:\/\/doi.org\/10.1128\/CMR.15.4.545-563.2002","journal-title":"Clin Microbiol Rev"},{"key":"18429_CR61","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","volume":"138","author":"M Feld","year":"2016","unstructured":"Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, Hevezi P, Plesser K, Schrumpf H, Krjutskov K, Sergeeva O (2016) The pruritus-and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol 138:500\u2013508. https:\/\/doi.org\/10.1016\/j.jaci.2016.02.020","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR62","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/02652048.2014.995727","volume":"32","author":"S Feng","year":"2015","unstructured":"Feng S, Nie L, Zou P, Suo J (2015) Drug-loaded PLGA-mPEG microparticles as treatment for atopic dermatitis-like skin lesions in BALB\/c mice model. J Microencapsul 32:201\u2013209. https:\/\/doi.org\/10.3109\/02652048.2014.995727","journal-title":"J Microencapsul"},{"key":"18429_CR63","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000358860","volume":"100","author":"CE Fern\u00e1ndez","year":"2014","unstructured":"Fern\u00e1ndez CE, Puerta L, Caraballo L (2014) Mites and allergy. Chem Immunol Allergy 100:234\u2013242. https:\/\/doi.org\/10.1159\/000358860","journal-title":"Chem Immunol Allergy"},{"key":"18429_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/all.12514","volume":"70","author":"KB Fieten","year":"2015","unstructured":"Fieten KB, Weststrate AC, Van Zuuren EJ, Bruijnzeel-Koomen CA, Pasmans SG (2015) Alpine climate treatment of atopic dermatitis: a systematic review. Allergy 70:12\u201325. https:\/\/doi.org\/10.1111\/all.12514","journal-title":"Allergy"},{"key":"18429_CR65","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jpeds.2007.05.018","volume":"151","author":"B Filipiak","year":"2007","unstructured":"Filipiak B, Zutavern A, Koletzko S, Von Berg A, Brockow I, Gr\u00fcbl A, Berdel D, Reinhardt D, Bauer CP, Wichmann HE, Heinrich J (2007) Solid food introduction in relation to eczema: results from a four-year prospective birth cohort study. J Pediatr 151:352\u2013358. https:\/\/doi.org\/10.1016\/j.jpeds.2007.05.018","journal-title":"J Pediatr"},{"key":"18429_CR66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.aller.2011.02.004","volume":"39","author":"C Flohr","year":"2011","unstructured":"Flohr C (2011) Recent perspectives on the global epidemiology of childhood eczema. Allergol Immunopathol (madr) 39:174\u2013182. https:\/\/doi.org\/10.1016\/j.aller.2011.02.004","journal-title":"Allergol Immunopathol (madr)"},{"key":"18429_CR67","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/all.12343","volume":"69","author":"C Flohr","year":"2014","unstructured":"Flohr C, Mann J (2014) New approaches to the prevention of childhood atopic dermatitis. Allergy 69:56\u201361. https:\/\/doi.org\/10.1111\/all.12343","journal-title":"Allergy"},{"key":"18429_CR68","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1365-2133.2011.10588.x","volume":"165","author":"C Flohr","year":"2011","unstructured":"Flohr C, Nagel G, Weinmayr G, Kleiner A, Strachan DP, Williams HC (2011) Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 165:1280\u20131289. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10588.x","journal-title":"Br J Dermatol"},{"key":"18429_CR69","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jaci.2005.04.006","volume":"115","author":"L Fonacier","year":"2005","unstructured":"Fonacier L, Spergel J, Charlesworth EN, Weldon D, Beltrani V, Bernhisel-Broadbent J, Boguniewicz M, Leung DY (2005) Report of the topical calcineurin inhibitor task force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 115:1249\u20131253. https:\/\/doi.org\/10.1016\/j.jaci.2005.04.006","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR70","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","volume":"66","author":"M Furue","year":"2017","unstructured":"Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, Kadono T (2017) Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int 66:398\u2013403. https:\/\/doi.org\/10.1016\/j.alit.2016.12.002","journal-title":"Allergol Int"},{"key":"18429_CR71","doi-asserted-by":"publisher","unstructured":"Fuxench ZC (2017) Atopic dermatitis: disease background and risk factors. Management of Atopic Dermatitis, 1st edn. Springer, Cham, Switzerland, 11\u201319. https:\/\/doi.org\/10.1007\/978-3-319-64804-0_2","DOI":"10.1007\/978-3-319-64804-0_2"},{"key":"18429_CR72","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jaad.2004.08.047","volume":"52","author":"T Gambichler","year":"2005","unstructured":"Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A (2005) Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 52:660\u2013670. https:\/\/doi.org\/10.1016\/j.jaad.2004.08.047","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.clindermatol.2014.12.004","volume":"33","author":"N Garg","year":"2015","unstructured":"Garg N, Silverberg JI (2015) Epidemiology of childhood atopic dermatitis. Clin Dermatol 33:281\u2013288. https:\/\/doi.org\/10.1016\/j.clindermatol.2014.12.004","journal-title":"Clin Dermatol"},{"key":"18429_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2310\/6620.2008.07068","volume":"19","author":"AC Gavino","year":"2008","unstructured":"Gavino AC, Needham GR, High WA (2008) Atopic dermatitis, patch testing, and house dust mites: a brief review. Dermatitis 19:121\u2013128. https:\/\/doi.org\/10.2310\/6620.2008.07068","journal-title":"Dermatitis"},{"key":"18429_CR75","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/medicina55080460","volume":"55","author":"A Giannetti","year":"2019","unstructured":"Giannetti A, Cipriani F, Indio V, Gallucci M, Caffarelli C, Ricci G (2019) Influence of atopic dermatitis on cow\u2019s milk allergy in children. Medicina 55:460. https:\/\/doi.org\/10.3390\/medicina55080460","journal-title":"Medicina"},{"key":"18429_CR76","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1208\/s12249-013-0017-3","volume":"14","author":"S Goindi","year":"2013","unstructured":"Goindi S, Kumar G, Kumar N, Kaur A (2013) Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. AAPS PharmSciTech 14:1284\u20131293. https:\/\/doi.org\/10.1208\/s12249-013-0017-3","journal-title":"AAPS PharmSciTech"},{"key":"18429_CR77","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/bjd.15165","volume":"177","author":"C-RRM Gonz\u00e1lez-LG","year":"2017","unstructured":"Gonz\u00e1lez-LG C-RRM, Gonz\u00e1lez-LJJ FRM, Herranz-PP, (2017) Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 177:688\u2013695. https:\/\/doi.org\/10.1111\/bjd.15165","journal-title":"Br J Dermatol"},{"key":"18429_CR78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2133.2001.04379.x","volume":"145","author":"H Gu","year":"2001","unstructured":"Gu H, Chen XS, Chen K, Yan Y, Jing H, Chen XQ, ShaoYe CGGY et al (2001) Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams in a hospital based setting. Br J Dermatol 145:428\u2013433. https:\/\/doi.org\/10.1111\/j.1365-2133.2001.04379.x","journal-title":"Br J Dermatol"},{"key":"18429_CR79","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1517\/14712598.2013.758708","volume":"13","author":"YE Guttman","year":"2013","unstructured":"Guttman YE, Dhingra N, Leung DY (2013) New era of biologic therapeutics in atopic dermatitis. Expert Opin Biol Ther 13:549\u2013561. https:\/\/doi.org\/10.1517\/14712598.2013.758708","journal-title":"Expert Opin Biol Ther"},{"key":"18429_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0019-5154.152573","volume":"2","author":"S Handa","year":"2015","unstructured":"Handa S, Jain N, Narang T (2015) Cost of care of atopic dermatitis in India. Indian J Dermatol 2:213. https:\/\/doi.org\/10.4103\/0019-5154.152573","journal-title":"Indian J Dermatol"},{"key":"18429_CR81","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1046\/j.1365-2133.2002.05006.x","volume":"147","author":"J Hanifin","year":"2002","unstructured":"Hanifin J, Gupta AK, Rajagopalan R (2002) Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 147:528\u2013537. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.05006.x","journal-title":"Br J Dermatol"},{"key":"18429_CR82","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jaad.2003.08.003","volume":"50","author":"JM Hanifin","year":"2004","unstructured":"Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, Schachner LA, Sidbury R, Whitmore SE, Sieck CK, Van Voorhees AS (2004) Guidelines of care for atopic dermatitis. J Am Acad Dermatol 50:391\u2013404. https:\/\/doi.org\/10.1016\/j.jaad.2003.08.003","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR83","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/08998280.2018.1480246","volume":"31","author":"IM Haugh","year":"2018","unstructured":"Haugh IM, Watson IT, Alan Menter M (2018) Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinib. Proc (bayl Univ Med Cent) 31:524\u2013525. https:\/\/doi.org\/10.1080\/08998280.2018.1480246","journal-title":"Proc (bayl Univ Med Cent)"},{"key":"18429_CR84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","volume":"79","author":"A He","year":"2018","unstructured":"He A, Feldman SR, Fleischer AB Jr (2018) An assessment of the use of antihistamines in the management of atopic dermatitis. J Am Acad Dermatol 79:92\u201396. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.077","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/09546634.2019.1689227","volume":"32","author":"AJ Hendricks","year":"2021","unstructured":"Hendricks AJ, Yosipovitch G, Shi VY (2021) Dupilumab use in dermatologic conditions beyond atopic dermatitis\u2013a systematic review. J Dermatolog Treat 32:19\u201328. https:\/\/doi.org\/10.1080\/09546634.2019.1689227","journal-title":"J Dermatolog Treat"},{"key":"18429_CR86","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00109-005-0672-2","volume":"83","author":"S Hoffjan","year":"2005","unstructured":"Hoffjan S, Epplen JT (2005) The genetics of atopic dermatitis: recent findings and future options. J Mol Med 83:682\u2013692. https:\/\/doi.org\/10.1007\/s00109-005-0672-2","journal-title":"J Mol Med"},{"key":"18429_CR87","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40629-015-0037-5","volume":"24","author":"S Hradetzky","year":"2015","unstructured":"Hradetzky S, Werfel T, R\u00f6sner LM (2015) Autoallergy in atopic dermatitis. Allergo J Int 24:16\u201322. https:\/\/doi.org\/10.1007\/s40629-015-0037-5","journal-title":"Allergo J Int"},{"key":"18429_CR88","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1542\/peds.2008-2217","volume":"123","author":"JT Huang","year":"2009","unstructured":"Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS (2009) Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123:e808\u2013e814. https:\/\/doi.org\/10.1542\/peds.2008-2217","journal-title":"Pediatrics"},{"key":"18429_CR89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpharm.2013.01.024","volume":"444","author":"Z Hussain","year":"2013","unstructured":"Hussain Z, Katas H, Amin MC, Kumolosasi E, Buang F, Sahudin S (2013) Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone\/hydroxytyrosol: an ex vivo and in vivo study using an NC\/Nga mouse model. Int J Pharm 444:109\u2013119. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.01.024","journal-title":"Int J Pharm"},{"key":"18429_CR90","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.2147\/IJN.S71543","volume":"9","author":"Z Hussain","year":"2014","unstructured":"Hussain Z, Katas H, Amin MC, Kumolosasi E, Sahudin S (2014) Downregulation of immunological mediators in 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles. Int J Nanomedicine 9:5143. https:\/\/doi.org\/10.2147\/IJN.S71543","journal-title":"Int J Nanomedicine"},{"key":"18429_CR91","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3109\/02652048.2014.932027","volume":"31","author":"A Jahn","year":"2014","unstructured":"Jahn A, Song CK, Balakrishnan P, Hong SS, Lee JH, Chung SJ, Kim DD (2014) AAPE proliposomes for topical atopic dermatitis treatment. J Microencapsul 31:768\u2013773. https:\/\/doi.org\/10.3109\/02652048.2014.932027","journal-title":"J Microencapsul"},{"key":"18429_CR92","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejpb.2011.05.012","volume":"79","author":"LB Jensen","year":"2011","unstructured":"Jensen LB, Petersson K, Nielsen HM (2011) In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm 79:68\u201375. https:\/\/doi.org\/10.1016\/j.ejpb.2011.05.012","journal-title":"Eur J Pharm Biopharm"},{"key":"18429_CR93","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1691\/ph.2011.0829","volume":"66","author":"SH Jung","year":"2011","unstructured":"Jung SH, Cho YS, Jun SS, Koo JS, Cheon HG, Shin BC (2011) Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy. Pharmazie 66:430\u2013435. https:\/\/doi.org\/10.1691\/ph.2011.0829","journal-title":"Pharmazie"},{"key":"18429_CR94","first-page":"396","volume":"22","author":"E Kami\u0144ska","year":"2008","unstructured":"Kami\u0144ska E (2008) The role of emollients in atopic dermatitis in children. Dev Period Med 22:396\u2013403","journal-title":"Dev Period Med"},{"key":"18429_CR95","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2147\/IJN.S215153","volume":"14","author":"JH Kang","year":"2019","unstructured":"Kang JH, Chon J, Kim YI, Lee HJ, Oh DW, Lee HG, Han CS, Kim DW, Park CW (2019) Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution. Int J Nanomedicine 14:5381. https:\/\/doi.org\/10.2147\/IJN.S215153","journal-title":"Int J Nanomedicine"},{"key":"18429_CR96","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1166\/jbn.2009.1053","volume":"5","author":"CM Keck","year":"2009","unstructured":"Keck CM, Schwabe K (2009) Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, in vivo efficiency and theory of action. J Biomed Nanotechnol 5:428\u2013436. https:\/\/doi.org\/10.1166\/jbn.2009.1053","journal-title":"J Biomed Nanotechnol"},{"key":"18429_CR97","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/1744666X.2020.1672537","volume":"15","author":"L Kem\u00e9ny","year":"2019","unstructured":"Kem\u00e9ny L, Varga E, Novak Z (2019) Advances in phototherapy for psoriasis and atopic dermatitis. Expert Rev Clin Immunol 15:1205\u20131214. https:\/\/doi.org\/10.1080\/1744666X.2020.1672537","journal-title":"Expert Rev Clin Immunol"},{"key":"18429_CR98","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/jid.2008.29","volume":"128","author":"S Kezic","year":"2008","unstructured":"Kezic S, Kemperman PM, Koster ES, de Jongh CM, Thio HB, Campbell LE, Irvine AD, McLean WI, Puppels GJ, Caspers PJ (2008) Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 128:2117\u20132119. https:\/\/doi.org\/10.1038\/jid.2008.29","journal-title":"J Invest Dermatol"},{"key":"18429_CR99","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan I, Saeed K, Khan I (2019) Nanoparticles: properties, applications and toxicities. Arab J Chem 12:908\u2013931. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.011","journal-title":"Arab J Chem"},{"key":"18429_CR100","unstructured":"Khan, Wahid, Shifrin, Helena, Schlinger, Ron, Avramoff, Avi, Domb, Avi. (2020) Fenoldopam topical formulations for treating skin disorders. IN201927011937."},{"key":"18429_CR101","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/jcm8040444","volume":"8","author":"JE Kim","year":"2019","unstructured":"Kim JE, Kim HS (2019) Microbiome of the skin and gut in atopic dermatitis (AD): understanding the pathophysiology and finding novel management strategies. J Clin Med 8:444. https:\/\/doi.org\/10.3390\/jcm8040444","journal-title":"J Clin Med"},{"key":"18429_CR102","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4168\/aair.2018.10.3.207","volume":"10","author":"BE Kim","year":"2018","unstructured":"Kim BE, Leung DY (2018) Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol Res 10:207\u2013215. https:\/\/doi.org\/10.4168\/aair.2018.10.3.207","journal-title":"Allergy Asthma Immunol Res"},{"key":"18429_CR103","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1691\/ph.2009.8373","volume":"64","author":"ST Kim","year":"2009","unstructured":"Kim ST, Jang DJ, Kim JH, Park JY, Lim JS, Lee SY, Lee KM, Lim SJ, Kim CK (2009) Topical administration of cyclosporin A in a solid lipid nanoparticle formulation. Pharmazie 64:510\u2013514. https:\/\/doi.org\/10.1691\/ph.2009.8373","journal-title":"Pharmazie"},{"key":"18429_CR104","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3346\/jkms.2013.28.1.74","volume":"28","author":"J Kim","year":"2013","unstructured":"Kim J, Lee S, Woo SY, Han Y, Lee JH, Lee IY, Lim IS, Choi ES, Choi BW, Cheong HK, Lee SI (2013) The indoor level of house dust mite allergen is associated with severity of atopic dermatitis in children. J Korean Med Sci 28:74\u201379. https:\/\/doi.org\/10.3346\/jkms.2013.28.1.74","journal-title":"J Korean Med Sci"},{"key":"18429_CR105","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/nu8120789","volume":"8","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Kim SN, Lee YW, Choe YB, Ahn KJ (2016) Vitamin D status and efficacy of vitamin D supplementation in atopic dermatitis: a systematic review and meta-analysis. Nutrients 8:789. https:\/\/doi.org\/10.3390\/nu8120789","journal-title":"Nutrients"},{"key":"18429_CR106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000068463","volume":"206","author":"K Kiriyama","year":"2003","unstructured":"Kiriyama K, Sugiura H, Uehara M (2003) Premenstrual deterioration of skin symptoms in female patients with atopic dermatitis. Dermatology 206:110\u2013112. https:\/\/doi.org\/10.1159\/000068463","journal-title":"Dermatology"},{"key":"18429_CR107","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.iac.2019.07.005","volume":"39","author":"MT Kraft","year":"2019","unstructured":"Kraft MT, Prince BT (2019) Atopic dermatitis is a barrier issue, not an allergy issue. Immunol Allergy Clin North Am 39:507\u2013519. https:\/\/doi.org\/10.1016\/j.iac.2019.07.005","journal-title":"Immunol Allergy Clin North Am"},{"key":"18429_CR108","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1542\/peds.2007-2232","volume":"122","author":"AC Krakowski","year":"2008","unstructured":"Krakowski AC, Eichenfield LF, Dohil MA (2008) Management of atopic dermatitis in the pediatric population. Pediatrics 122:812\u2013824. https:\/\/doi.org\/10.1542\/peds.2007-2232","journal-title":"Pediatrics"},{"key":"18429_CR109","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1080\/09205063.2015.1100844","volume":"26","author":"P Kumar","year":"2015","unstructured":"Kumar P, Hosain MZ, Kang JH, Takeo M, Kishimura A, Mori T, Katayama Y (2015) Suppression of atopic dermatitis in mice model by reducing inflammation utilizing phosphatidylserine-coated biodegradable microparticles. J Biomater Sci Polym Ed 26:1465\u20131474. https:\/\/doi.org\/10.1080\/09205063.2015.1100844","journal-title":"J Biomater Sci Polym Ed"},{"key":"18429_CR110","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s13346-012-0060-8","volume":"2","author":"MS Lalan","year":"2012","unstructured":"Lalan MS, Laddha NC, Lalani J, Imran MJ, Begum R, Misra A (2012) Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis. Drug Deliv and Transl Res 2:129\u2013141. https:\/\/doi.org\/10.1007\/s13346-012-0060-8","journal-title":"Drug Deliv and Transl Res"},{"key":"18429_CR111","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1468-3083.2007.02277.x","volume":"21","author":"JH Lee","year":"2007","unstructured":"Lee JH, Lee SJ, Kim DS, Bang D (2007a) The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. J Eur Acad Dermatol Venereol 21:1360\u20131368. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02277.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"18429_CR112","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2133.2007.08215.x","volume":"157","author":"YL Lee","year":"2007","unstructured":"Lee YL, Li CW, Sung FC, Yu HS, Sheu HM, Guo YL (2007b) Environmental factors, parental atopy and atopic eczema in primary-school children: a cross-sectional study in Taiwan. Br J Dermatol 157:1217\u20131224. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08215.x","journal-title":"Br J Dermatol"},{"key":"18429_CR113","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4168\/aair.2016.8.3.181","volume":"8","author":"JH Lee","year":"2016","unstructured":"Lee JH, Son SW, Cho SH (2016) A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res 8:181\u2013190. https:\/\/doi.org\/10.4168\/aair.2016.8.3.181","journal-title":"Allergy Asthma Immunol Res"},{"key":"18429_CR114","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1067\/mai.2000.106484","volume":"105","author":"DY Leung","year":"2000","unstructured":"Leung DY (2000) Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105:860\u2013876. https:\/\/doi.org\/10.1067\/mai.2000.106484","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR115","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00008480-200308000-00008","volume":"15","author":"DY Leung","year":"2003","unstructured":"Leung DY (2003) Infection in atopic dermatitis. Curr Opin Pediatr 15:399\u2013404. https:\/\/doi.org\/10.1097\/00008480-200308000-00008","journal-title":"Curr Opin Pediatr"},{"key":"18429_CR116","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI21060","volume":"113","author":"DY Leung","year":"2004","unstructured":"Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA (2004) New insights into atopic dermatitis. J Clin Investig 113:651\u2013657. https:\/\/doi.org\/10.1172\/JCI21060","journal-title":"J Clin Investig"},{"key":"18429_CR117","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaad.2015.06.045","volume":"73","author":"LL Levy","year":"2015","unstructured":"Levy LL, Urban J, King BA (2015) Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate. J Am Acad Dermatol 73:395\u2013399. https:\/\/doi.org\/10.1016\/j.jaad.2015.06.045","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR118","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.det.2007.06.009","volume":"25","author":"J Lipozen\u010di\u0107","year":"2007","unstructured":"Lipozen\u010di\u0107 J, Wolf R (2007) Atopic dermatitis: an update and review of the literature. Dermatol Clin 25:605\u2013612. https:\/\/doi.org\/10.1016\/j.det.2007.06.009","journal-title":"Dermatol Clin"},{"key":"18429_CR119","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","volume":"328","author":"J Liu","year":"2007","unstructured":"Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X (2007) Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 328:191\u2013195. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.08.007","journal-title":"Int J Pharm"},{"key":"18429_CR120","unstructured":"Lueras, Alexis, Sloey, Christopher, Tally, Clea. (2021) Formulations of human Anti-TSLP antibodies and methods of treating inflammatory disease. WO2021163504."},{"key":"18429_CR121","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jdermsci.2021.04.007","volume":"102","author":"T Luger","year":"2021","unstructured":"Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K, Schikowski T, Proksch E, Elias PM, Simon M, Simpson E (2021) Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 102:142\u2013157. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.04.007","journal-title":"J Dermatol Sci"},{"key":"18429_CR122","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.iac.2014.09.008","volume":"35","author":"JJ Lyons","year":"2015","unstructured":"Lyons JJ, Milner JD, Stone KD (2015) Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am 35:161\u2013183. https:\/\/doi.org\/10.1016\/j.iac.2014.09.008","journal-title":"Immunol Allergy Clin North Am"},{"key":"18429_CR123","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/2230-973X.133047","volume":"4","author":"JR Madan","year":"2014","unstructured":"Madan JR, Khude PA, Dua K (2014) Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery. Int J Pharm Investig 4:60. https:\/\/doi.org\/10.4103\/2230-973X.133047","journal-title":"Int J Pharm Investig"},{"key":"18429_CR124","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.det.2017.02.006","volume":"35","author":"K Malik","year":"2017","unstructured":"Malik K, Heitmiller KD, Czarnowicki T (2017) An update on the pathophysiology of atopic dermatitis. Dermatol Clin 35:317\u2013326. https:\/\/doi.org\/10.1016\/j.det.2017.02.006","journal-title":"Dermatol Clin"},{"key":"18429_CR125","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/ACI.0000000000000194","volume":"15","author":"I Marenholz","year":"2015","unstructured":"Marenholz I, Esparza-Gordillo J, Lee Y (2015) The genetics of the skin barrier in eczema and other allergic disorders. Curr Opin Allergy Clin Immunol 15:426\u2013434. https:\/\/doi.org\/10.1097\/ACI.0000000000000194","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"18429_CR126","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.aller.2013.03.005","volume":"41","author":"A Martorell","year":"2013","unstructured":"Martorell A, Alonso E, Bon\u00e9 J, Echeverr\u00eda L, L\u00f3pez MC, Mart\u00edn F, Nevot S, Plaza AM (2013) Allergy committee of SEICAP F. Position document IgE mediated allergy to egg protein Allergol Immunopathol (madr) 41:320\u2013336. https:\/\/doi.org\/10.1016\/j.aller.2013.03.005","journal-title":"Position document IgE mediated allergy to egg protein Allergol Immunopathol (madr)"},{"key":"18429_CR127","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/pai.12831","volume":"28","author":"C Mastrorilli","year":"2017","unstructured":"Mastrorilli C, Caffarelli C, Hoffmann Sommergruber K (2017) Food allergy and atopic dermatitis: prediction, progression, and prevention. Pediatr Allergy Immunol 28:831\u2013840. https:\/\/doi.org\/10.1111\/pai.12831","journal-title":"Pediatr Allergy Immunol"},{"key":"18429_CR128","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1203475416685077","volume":"21","author":"JN Mayba","year":"2017","unstructured":"Mayba JN, Gooderham MJ (2017) Review of atopic dermatitis and topical therapies. J Cutan Med Surg 21:227\u2013236. https:\/\/doi.org\/10.1177\/1203475416685077","journal-title":"J Cutan Med Surg"},{"key":"18429_CR129","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","volume":"131","author":"MA McAleer","year":"2013","unstructured":"McAleer MA, Irvine AD (2013) The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol 131:280\u2013291. https:\/\/doi.org\/10.1016\/j.jaci.2012.12.668","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR130","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12016-018-8693-0","volume":"57","author":"JD Miller","year":"2019","unstructured":"Miller JD (2019) The role of dust mites in allergy. Clin Rev Allergy Immunol 57:312\u2013329. https:\/\/doi.org\/10.1007\/s12016-018-8693-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"18429_CR131","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-2222.2004.01915.x","volume":"34","author":"MF Moffatt","year":"2004","unstructured":"Moffatt MF (2004) SPINK5: a gene for atopic dermatitis and asthma. Clin Exp Allergy 34:325\u2013327. https:\/\/doi.org\/10.1111\/j.1365-2222.2004.01915.x","journal-title":"Clin Exp Allergy"},{"key":"18429_CR132","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaci.2006.03.037","volume":"118","author":"N Morar","year":"2006","unstructured":"Morar N, Willis-Owen SA, Moffatt MF, Cookson WO (2006) The genetics of atopic dermatitis. J Allergy Clin Immunol 118:24\u201334. https:\/\/doi.org\/10.1016\/j.jaci.2006.03.037","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR133","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jdermsci.2015.05.010","volume":"79","author":"H Murota","year":"2015","unstructured":"Murota H, Takeuchi S, Sugaya M, Tanioka M, Onozuka D, Hagihara A, Saeki H, Imafuku S, Abe M, Shintani Y, Kaneko S (2015) Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation. J Dermatol Sci 79:279\u2013287. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.05.010","journal-title":"J Dermatol Sci"},{"key":"18429_CR134","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/children6120133","volume":"6","author":"CH Na","year":"2019","unstructured":"Na CH, Chung J, Simpson EL (2019) Quality of life and disease impact of atopic dermatitis and psoriasis on children and their families. Children 6:133. https:\/\/doi.org\/10.3390\/children6120133","journal-title":"Children"},{"key":"18429_CR135","doi-asserted-by":"publisher","first-page":"558","DOI":"10.23736\/s0392-0488.20.06582-7","volume":"156","author":"M Napolitano","year":"2020","unstructured":"Napolitano M, Monfrecola G, Fabbrocini G, Fattore D, Patr\u00ed A, Patruno C (2020) Impact of sun exposure on adult patients affected by atopic dermatitis. G Ital Dermatol Venereol 156:558\u2013561. https:\/\/doi.org\/10.23736\/s0392-0488.20.06582-7","journal-title":"G Ital Dermatol Venereol"},{"key":"18429_CR136","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.14207","volume":"174","author":"O Nemoto","year":"2016","unstructured":"Nemoto O, Furue M, Nakagawa H, Shiramoto M, Hanada R, Matsuki S, Imayama S, Kato M, Hasebe I, Taira K, Yamamoto M (2016) The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study. Br J Dermatol 174:296\u2013304. https:\/\/doi.org\/10.1111\/bjd.14207","journal-title":"Br J Dermatol"},{"key":"18429_CR137","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/jdv.12864","volume":"29","author":"JP Ng","year":"2015","unstructured":"Ng JP, Liew HM, Ang SB (2015) Use of emollients in atopic dermatitis. J Eur Acad Dermatol Venereol 29:854\u2013857. https:\/\/doi.org\/10.1111\/jdv.12864","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"18429_CR138","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.iac.2016.08.003","volume":"37","author":"NH Nicol","year":"2017","unstructured":"Nicol NH, Boguniewicz M (2017) Wet wrap therapy in moderate to severe atopic dermatitis. Immunol Allergy Clin North Am 37:123\u2013139. https:\/\/doi.org\/10.1016\/j.iac.2016.08.003","journal-title":"Immunol Allergy Clin North Am"},{"key":"18429_CR139","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","volume":"171","author":"I Nomura","year":"2003","unstructured":"Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262\u20133269. https:\/\/doi.org\/10.4049\/jimmunol.171.6.3262","journal-title":"J Immunol"},{"key":"18429_CR140","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","volume":"66","author":"S Nutten","year":"2015","unstructured":"Nutten S (2015) Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 66:8\u201316. https:\/\/doi.org\/10.1159\/000370220","journal-title":"Ann Nutr Metab"},{"key":"18429_CR141","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000484407","volume":"233","author":"U Nygaard","year":"2017","unstructured":"Nygaard U, Deleuran M, Vestergaard C (2017) Emerging treatment options in atopic dermatitis: topical therapies. Dermatology 233:333\u2013343. https:\/\/doi.org\/10.1159\/000484407","journal-title":"Dermatology"},{"key":"18429_CR142","doi-asserted-by":"publisher","first-page":"567090","DOI":"10.3389\/fmicb.2020.567090","volume":"11","author":"P Ogonowska","year":"2020","unstructured":"Ogonowska P, Gilaberte Y, Bara\u0144ska-Rybak W, Nakonieczna J (2020) Colonization with Staphylococcus aureus in atopic dermatitis patients: attempts to reveal the unknown. Front Microbiol 11:567090. https:\/\/doi.org\/10.3389\/fmicb.2020.567090","journal-title":"Front Microbiol"},{"key":"18429_CR143","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJMoa021481","volume":"347","author":"PY Ong","year":"2002","unstructured":"Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151\u20131160. https:\/\/doi.org\/10.1056\/NEJMoa021481","journal-title":"N Engl J Med"},{"key":"18429_CR144","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2222.2010.03522.x","volume":"40","author":"GM O'Regan","year":"2010","unstructured":"O\u2019Regan GM, Irvine AD (2010) The role of filaggrin in the atopic diathesis. Clin Exp Allergy 40:965\u2013972. https:\/\/doi.org\/10.1111\/j.1365-2222.2010.03522.x","journal-title":"Clin Exp Allergy"},{"key":"18429_CR145","doi-asserted-by":"publisher","unstructured":"Osborn DA, Sinn JK (2013) Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev CD006474. https:\/\/doi.org\/10.1002\/14651858.CD006474.pub3","DOI":"10.1002\/14651858.CD006474.pub3"},{"key":"18429_CR146","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12247-020-09465-x","volume":"16","author":"RR Pal","year":"2021","unstructured":"Pal RR, Maurya AK, Parashar P, Saraf SA (2021) A comparative study of levocetirizine loaded vesicular and matrix type system for topical application: appraisal of therapeutic potential against atopic dermatitis. J Pharm Innov 16:469\u2013480. https:\/\/doi.org\/10.1007\/s12247-020-09465-x","journal-title":"J Pharm Innov"},{"key":"18429_CR147","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O\u2019Regan GM (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441\u2013446. https:\/\/doi.org\/10.1038\/ng1767","journal-title":"Nat Genet"},{"key":"18429_CR148","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13346-018-0480-1","volume":"9","author":"M Pandey","year":"2019","unstructured":"Pandey M, Choudhury H, Gunasegaran TA, Nathan SS, Md S, Gorain B, Tripathy M, Hussain Z (2019) Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting. Drug Deliv Transl Res 9:520\u2013533. https:\/\/doi.org\/10.1007\/s13346-018-0480-1","journal-title":"Drug Deliv Transl Res"},{"key":"18429_CR149","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2010.10.007","volume":"126","author":"Panel NS","year":"2010","unstructured":"Panel NS (2010) Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 126:S1\u2013S58. https:\/\/doi.org\/10.1016\/j.jaci.2010.10.007","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR150","doi-asserted-by":"publisher","first-page":"212521","DOI":"10.7573\/dic.212521","volume":"7","author":"A Papier","year":"2018","unstructured":"Papier A, Strowd LC (2018) Atopic dermatitis: a review of topical nonsteroid therapy. Drugs Context 7:212521. https:\/\/doi.org\/10.7573\/dic.212521","journal-title":"Drugs Context"},{"key":"18429_CR151","first-page":"463","volume":"144","author":"A Patrizi","year":"2009","unstructured":"Patrizi A, Savoia F, Giacomini F, Tabanelli M, Gurioli C (2009) The effect of summer holidays and sun exposure on atopic dermatitis. G Ital Dermatol Venereol 144:463\u2013466","journal-title":"G Ital Dermatol Venereol"},{"key":"18429_CR152","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/EDE.0b013e31824d5da2","volume":"23","author":"C Pelucchi","year":"2012","unstructured":"Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach JF, La Vecchia C (2012) Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 23:402\u2013414. https:\/\/doi.org\/10.1097\/EDE.0b013e31824d5da2","journal-title":"Epidemiology"},{"key":"18429_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2018.11.007","volume":"46","author":"MP Pereira","year":"2019","unstructured":"Pereira MP, Mittal A, St\u00e4nder S (2019) Current treatment strategies in refractory chronic pruritus. Curr Opin Pharmacol 46:1\u20136. https:\/\/doi.org\/10.1016\/j.coph.2018.11.007","journal-title":"Curr Opin Pharmacol"},{"key":"18429_CR154","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijpharm.2010.07.008","volume":"398","author":"PV Pople","year":"2010","unstructured":"Pople PV, Singh KK (2010) Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Int J Pharm 398:165\u2013178. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.07.008","journal-title":"Int J Pharm"},{"key":"18429_CR155","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2133.2005.06540.x","volume":"152","author":"DJ Purvis","year":"2005","unstructured":"Purvis DJ, Thompson JM, Clark PM, Robinson E, Black PN, Wild CJ, Mitchell EA (2005) Risk factors for atopic dermatitis in New Zealand children at 3\u00b7 5 years of age. Br J Dermatol 152:742\u2013749. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06540.x","journal-title":"Br J Dermatol"},{"key":"18429_CR156","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4168\/aair.2015.7.2.101","volume":"7","author":"BY Pyun","year":"2015","unstructured":"Pyun BY (2015) Natural history and risk factors of atopic dermatitis in children. Allergy Asthma Immunol Res 7:101\u2013105. https:\/\/doi.org\/10.4168\/aair.2015.7.2.101","journal-title":"Allergy Asthma Immunol Res"},{"key":"18429_CR157","unstructured":"Railkar Aruna, Jariwala Paras, Phuapradit Wantanee, Zammit David, Denis Louis, Rao Niranjan, Usansky Helen, Gupta Sandeep. (2020) Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient. EP3615032."},{"key":"18429_CR158","unstructured":"Railkar Aruna, Jariwala Paras, Phuapradit Wantanee, Zammit David, Denis Louis, Rao Niranjan, Usansky Helen, Gupta Sandeep. (2020) Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of active pharmaceutical ingredient. CN110809471"},{"key":"18429_CR159","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1080\/17425247.2020.1813107","volume":"17","author":"EV Ramos Campos","year":"2020","unstructured":"Ramos Campos EV, Proen\u00e7a PL, Doretto-Silva L, Andrade-Oliveira V, Fraceto LF, de Araujo DR (2020) Trends in nanoformulations for atopic dermatitis treatment. Expert Opin Drug Deliv 17:1615\u20131630. https:\/\/doi.org\/10.1080\/17425247.2020.1813107","journal-title":"Expert Opin Drug Deliv"},{"key":"18429_CR160","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2500\/aap.2018.39.4175","volume":"39","author":"B Reed","year":"2018","unstructured":"Reed B, Blaiss MS (2018) The burden of atopic dermatitis. Allergy Asthma Proc 39:406\u2013410. https:\/\/doi.org\/10.2500\/aap.2018.39.4175","journal-title":"Allergy Asthma Proc"},{"key":"18429_CR161","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ACI.0000000000000455","volume":"18","author":"Y Renert-Yuval","year":"2018","unstructured":"Renert-Yuval Y, Guttman-Yassky E (2018) Monoclonal antibodies for the treatment of atopic dermatitis. Curr Opin Allergy Clin Immunol 18:356\u2013364. https:\/\/doi.org\/10.1097\/ACI.0000000000000455","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"18429_CR162","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.clindermatol.2016.05.011","volume":"34","author":"DL Rodenbeck","year":"2016","unstructured":"Rodenbeck DL, Silverberg JI, Silverberg NB (2016) Phototherapy for atopic dermatitis. Clin Dermatol 34:607\u2013613. https:\/\/doi.org\/10.1016\/j.clindermatol.2016.05.011","journal-title":"Clin Dermatol"},{"key":"18429_CR163","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaci.2012.02.043","volume":"130","author":"C Roduit","year":"2012","unstructured":"Roduit C, Frei R, Loss G, B\u00fcchele G, Weber J, Depner M, Loeliger S, Dalphin ML, Roponen M, Hyv\u00e4rinen A, Riedler J (2012) Development of atopic dermatitis according to age of onset and association with early-life exposures. J Allergy Clin Immunol 130:130\u2013136. https:\/\/doi.org\/10.1016\/j.jaci.2012.02.043","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR164","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.anai.2016.01.022","volume":"116","author":"EM Roerdink","year":"2016","unstructured":"Roerdink EM, Flokstra-de Blok BM, Blok JL, Schuttelaar ML, Niggemann B, Werfel T, Van der Heide S, Kukler J, Kollen BJ, Dubois AE (2016) Association of food allergy and atopic dermatitis exacerbations. Ann Allergy Asthma Immunol 116:334\u2013338. https:\/\/doi.org\/10.1016\/j.anai.2016.01.022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"18429_CR165","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3109\/10837450.2012.712537","volume":"18","author":"C Rosado","year":"2013","unstructured":"Rosado C, Silva C, Reis CP (2013) Hydrocortisone-loaded poly (\u03b5-caprolactone) nanoparticles for atopic dermatitis treatment. Pharm Dev Technol 18:710\u2013718. https:\/\/doi.org\/10.3109\/10837450.2012.712537","journal-title":"Pharm Dev Technol"},{"key":"18429_CR166","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/1346-8138.13392","volume":"43","author":"H Saeki","year":"2016","unstructured":"Saeki H, Nakahara T, Tanaka A, Kabashima K, Sugaya M, Murota H, Ebihara T, Kataoka Y, Aihara M, Etoh T, Katoh N (2016) Clinical practice guidelines for the management of atopic dermatitis 2016. J Dermatol 43:1117\u20131145. https:\/\/doi.org\/10.1111\/1346-8138.13392","journal-title":"J Dermatol"},{"key":"18429_CR167","unstructured":"Samuelsson BI, Ming G (2020a) Topical formulations comprising montelukast and combinations with mussel adhesive proteins. SG11201911841P"},{"key":"18429_CR168","unstructured":"Samuelsson, Bengt Ingemar, Gu Ming. (2020) Topical formulations comprising montelukast and combinations with mussel adhesive proteins, EP3648767."},{"key":"18429_CR169","unstructured":"Samuelsson BI, Ming G, Ming Gu. (2021) Topical formulations comprising montelukast and combinations with mussel adhesive proteins. US20210145819."},{"key":"18429_CR170","unstructured":"Samuelsson, Bengt Ingemar. (2020) new formulations containing leukotriene receptor antagonists. WO2020143744"},{"key":"18429_CR171","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13223-018-0281-6","volume":"14","author":"K Sandeep","year":"2018","unstructured":"Sandeep K, Wade W, Stuart C (2018) Atopic dermatitis. Allergy Asthma. Clin Immunol 14:52. https:\/\/doi.org\/10.1186\/s13223-018-0281-6","journal-title":"Clin Immunol"},{"key":"18429_CR172","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/1061186021000038364","volume":"10","author":"C Santos Maia","year":"2002","unstructured":"Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Sch\u00e4fer-Korting M (2002) Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 10:489\u2013495. https:\/\/doi.org\/10.1080\/1061186021000038364","journal-title":"J Drug Target"},{"key":"18429_CR173","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1399-3038.2009.00899.x","volume":"21","author":"M Sariachvili","year":"2010","unstructured":"Sariachvili M, Droste J, Dom S, Wieringa M, Hagendorens M, Stevens W, Van Sprundel M, Desager K, Weyler J (2010) Early exposure to solid foods and the development of eczema in children up to 4 years of age. Pediatr Allergy Immunol 21:74\u201381. https:\/\/doi.org\/10.1111\/j.1399-3038.2009.00899.x","journal-title":"Pediatr Allergy Immunol"},{"key":"18429_CR174","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2133.2010.10030.x","volume":"164","author":"J Schmitt","year":"2011","unstructured":"Schmitt J, von Kobyletzki L, Svensson \u00c5, Apfelbacher C (2011) Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 164:415\u2013428. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10030.x","journal-title":"Br J Dermatol"},{"key":"18429_CR175","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000051811","volume":"204","author":"C Schnopp","year":"2002","unstructured":"Schnopp C, Holtmann C, Stock S, Remling R, F\u00f6lster-Holst R, Ring J, Abeck D (2002) Topical steroids under wet-wrap dressings in atopic dermatitis\u2013a vehicle-controlled trial. Dermatology 204:56\u201359. https:\/\/doi.org\/10.1159\/000051811","journal-title":"Dermatology"},{"key":"18429_CR176","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/17512433.2018.1449642","volume":"11","author":"M Seegr\u00e4ber","year":"2018","unstructured":"Seegr\u00e4ber M, Srour J, Walter A, Knop M, Wollenberg A (2018) Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol 11:467\u2013474. https:\/\/doi.org\/10.1080\/17512433.2018.1449642","journal-title":"Expert Rev Clin Pharmacol"},{"key":"18429_CR177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1710-1492-9-24","volume":"9","author":"AO Segal","year":"2013","unstructured":"Segal AO, Ellis AK, Kim HL (2013) CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. Allergy Asthma Clin Immunol 9:1\u20133. https:\/\/doi.org\/10.1186\/1710-1492-9-24","journal-title":"Allergy Asthma Clin Immunol"},{"key":"18429_CR178","doi-asserted-by":"publisher","first-page":"583946","DOI":"10.3389\/fped.2020.583946","volume":"8","author":"S Sestito","year":"2020","unstructured":"Sestito S, D\u2019Auria E, Baldassarre ME, Salvatore S, Tallarico V, Stefanelli E, Tarsitano F, Concolino D, Pensabene L (2020) The role of prebiotics and probiotics in prevention of allergic diseases in infants. Front Pediatr 8:583946. https:\/\/doi.org\/10.3389\/fped.2020.583946","journal-title":"Front Pediatr"},{"key":"18429_CR179","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","volume":"345","author":"KA Shah","year":"2007","unstructured":"Shah KA, Date AA, Joshi MD, Patravale VB (2007) Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 345:163\u2013171. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.05.061","journal-title":"Int J Pharm"},{"key":"18429_CR180","unstructured":"Stuart D. Shanler, Christopher Powala, Luis Rios. (2020) Pharmaceutical cream compositions and methods of use.US20200188517."},{"key":"18429_CR181","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jid.2010.251","volume":"131","author":"TE Shaw","year":"2011","unstructured":"Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children\u2019s Health. J Invest Dermatol 131:67\u201373. https:\/\/doi.org\/10.1038\/jid.2010.251","journal-title":"J Invest Dermatol"},{"key":"18429_CR182","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.clindermatol.2018.05.008","volume":"36","author":"R Sidbury","year":"2018","unstructured":"Sidbury R, Kodama S (2018) Atopic dermatitis guidelines: diagnosis, systemic therapy, and adjunctive care. Clin Dermatol 36:648\u2013652. https:\/\/doi.org\/10.1016\/j.clindermatol.2018.05.008","journal-title":"Clin Dermatol"},{"key":"18429_CR183","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijpharm.2016.05.005","volume":"507","author":"MI Siddique","year":"2016","unstructured":"Siddique MI, Katas H, Amin MC, Ng SF, Zulfakar MH, Jamil A (2016) In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis. Int J Pharm 507:72\u201382. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.05.005","journal-title":"Int J Pharm"},{"key":"18429_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-016-0607-9","volume":"16","author":"EC Siegfried","year":"2016","unstructured":"Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA (2016) Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr 16:1\u20135. https:\/\/doi.org\/10.1186\/s12887-016-0607-9","journal-title":"BMC Pediatr"},{"key":"18429_CR185","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.clindermatol.2017.03.003","volume":"35","author":"NB Silverberg","year":"2017","unstructured":"Silverberg NB, Silverberg JI (2017) Atopic dermatitis: Part I. Clin Dermatol 35:341\u2013343. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.03.003","journal-title":"Clin Dermatol"},{"key":"18429_CR186","doi-asserted-by":"publisher","first-page":"78","DOI":"10.18176\/jiaci.0138","volume":"27","author":"SJF Silvestre","year":"2017","unstructured":"Silvestre SJF, Romero-P\u00e9rez D, Encabo-Dur\u00e1n B (2017) Atopic dermatitis in adults: a diagnostic challenge. J Investig Allergol Clin Immunol 27:78\u201388. https:\/\/doi.org\/10.18176\/jiaci.0138","journal-title":"J Investig Allergol Clin Immunol"},{"key":"18429_CR187","unstructured":"Sim, Je Duk. (2020) Composition for preventing or alleviating atopic dermatitis and method for manufacturing same. KR1020200029981."},{"key":"18429_CR188","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","volume":"75","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Gadkari A, Worm M, Soong W, Blauvelt A, Eckert L, Wu R, Ardeleanu M, Graham NM, Pirozzi G, Sutherland ER (2016) Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). J Am Acad Dermatol 75:506\u2013515. https:\/\/doi.org\/10.1016\/j.jaad.2016.04.054","journal-title":"J Am Acad Dermatol"},{"key":"18429_CR189","unstructured":"Singh, Paramjit, Panda, Debendra, Kumar, Price, Jeffrey, Ellis, Badhan, Atul, Chhagan, Cunningham, Nicholas, Finn. (2020) Palatable formulations. WO2020172232."},{"key":"18429_CR190","doi-asserted-by":"publisher","first-page":"137","DOI":"10.12932\/AP0825","volume":"35","author":"S Somanunt","year":"2017","unstructured":"Somanunt S, Chinratanapisit S, Pacharn P, Visitsunthorn N, Jirapongsananuruk O (2017) The natural history of atopic dermatitis and its association with Atopic March. Asian Pac J Allergy Immunol 35:137\u2013143. https:\/\/doi.org\/10.12932\/AP0825","journal-title":"Asian Pac J Allergy Immunol"},{"key":"18429_CR191","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.3390\/ijms20225659","volume":"20","author":"EB Souto","year":"2019","unstructured":"Souto EB, Dias-Ferreira J, Oliveira J, Sanchez-Lopez E, Lopez-Machado A, Espina M, Garcia ML, Souto SB, Martins-Gomes C, Silva AM (2019) Trends in atopic dermatitis\u2014from standard pharmacotherapy to novel drug delivery systems. Int J Mol Sci 20:5659. https:\/\/doi.org\/10.3390\/ijms20225659","journal-title":"Int J Mol Sci"},{"key":"18429_CR192","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.iac.2010.06.003","volume":"30","author":"JM Spergel","year":"2010","unstructured":"Spergel JM (2010) Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am 30:269\u2013280. https:\/\/doi.org\/10.1016\/j.iac.2010.06.003","journal-title":"Immunol Allergy Clin North Am"},{"key":"18429_CR193","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.jaci.2003.09.033","volume":"112","author":"JM Spergel","year":"2003","unstructured":"Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:S118\u2013S127. https:\/\/doi.org\/10.1016\/j.jaci.2003.09.033","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR194","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.alit.2019.08.013","volume":"69","author":"K Sugita","year":"2020","unstructured":"Sugita K, Akdis CA (2020) Recent developments and advances in atopic dermatitis and food allergy. Allergol Int 69:204\u2013214. https:\/\/doi.org\/10.1016\/j.alit.2019.08.013","journal-title":"Allergol Int"},{"key":"18429_CR195","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1525-1470.2008.00768.x","volume":"25","author":"L Suh","year":"2008","unstructured":"Suh L, Coffin S, Leckerman KH, Gelfand JM, Honig PJ, Yan AC (2008) Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermaitis. Pediatr Dermatol 25:528\u2013534. https:\/\/doi.org\/10.1111\/j.1525-1470.2008.00768.x","journal-title":"Pediatr Dermatol"},{"key":"18429_CR196","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clindermatol.2017.03.006","volume":"35","author":"M Sullivan","year":"2017","unstructured":"Sullivan M, Silverberg NB (2017) Current and emerging concepts in atopic dermatitis pathogenesis. Clin Dermatol 35:349\u2013353. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.03.006","journal-title":"Clin Dermatol"},{"key":"18429_CR197","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1185\/03007990903510317","volume":"26","author":"H Szajewska","year":"2010","unstructured":"Szajewska H, Horvath A (2010) Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 26:423\u2013437. https:\/\/doi.org\/10.1185\/03007990903510317","journal-title":"Curr Med Res Opin"},{"key":"18429_CR198","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/s0001-4079(19)31798-4","volume":"196","author":"A Taieb","year":"2012","unstructured":"Taieb A (2012) Atopic dermatitis: pathophysiology update. Bull Acad Natl Med 196:621\u2013629. https:\/\/doi.org\/10.1016\/s0001-4079(19)31798-4","journal-title":"Bull Acad Natl Med"},{"key":"18429_CR199","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2133.2006.07636.x","volume":"156","author":"N Takano","year":"2007","unstructured":"Takano N, Sakurai T, Ohashi Y, Kurachi M (2007) Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC\/Nga mouse atopic dermatitis model. Br J Dermatol 156:241\u2013246. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07636.x","journal-title":"Br J Dermatol"},{"key":"18429_CR200","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ejpb.2018.02.037","volume":"127","author":"EN Tessema","year":"2018","unstructured":"Tessema EN, Gebre-Mariam T, Paulos G, Wohlrab J, Neubert RH (2018) Delivery of oat-derived phytoceramides into the stratum corneum of the skin using nanocarriers: formulation, characterization and in vitro and ex-vivo penetration studies. Eur J Pharm Biopharm 127:260\u2013269. https:\/\/doi.org\/10.1016\/j.ejpb.2018.02.037","journal-title":"Eur J Pharm Biopharm"},{"key":"18429_CR201","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/bmj.324.7340.768","volume":"324","author":"KS Thomas","year":"2002","unstructured":"Thomas KS, Armstrong S, Avery A, Po AL, O\u2019Neill C, Young S, Williams HC (2002) Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 324:768. https:\/\/doi.org\/10.1136\/bmj.324.7340.768","journal-title":"BMJ"},{"key":"18429_CR202","doi-asserted-by":"publisher","first-page":"24642","DOI":"10.3402\/ecrj.v2.24642","volume":"2","author":"SF Thomsen","year":"2015","unstructured":"Thomsen SF (2015) Epidemiology and natural history of atopic diseases. Eur Clin Respir J 2:24642. https:\/\/doi.org\/10.3402\/ecrj.v2.24642","journal-title":"Eur Clin Respir J"},{"key":"18429_CR203","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2500\/aap2007.28.3041","volume":"28","author":"SF Thomsen","year":"2007","unstructured":"Thomsen SF, Ulrik CS, Kyvik KO, Hjelmborg JV, Skadhauge LR, Steffensen I, Backer V (2007) Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy Asthma Proc 28:535\u2013539. https:\/\/doi.org\/10.2500\/aap2007.28.3041","journal-title":"Allergy Asthma Proc"},{"key":"18429_CR204","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/ijd.13401","volume":"55","author":"SF Thomsen","year":"2016","unstructured":"Thomsen SF, Elmose C, Szecsi PB, Stender S, Kyvik KO, Backer V, Thyssen JP (2016) Filaggrin gene loss-of-function mutations explain discordance of atopic dermatitis within dizygotic twin pairs. Int J Dermatol 55:1341\u20131344. https:\/\/doi.org\/10.1111\/ijd.13401","journal-title":"Int J Dermatol"},{"key":"18429_CR205","doi-asserted-by":"publisher","unstructured":"Thomsen SF (2014) Atopic dermatitis: natural history, diagnosis, and treatment. ISRN 2014. https:\/\/doi.org\/10.1155\/2014\/354250","DOI":"10.1155\/2014\/354250"},{"key":"18429_CR206","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5114\/ada.2018.77056","volume":"36","author":"H Tomczak","year":"2019","unstructured":"Tomczak H, Wr\u00f3bel J, Jenerowicz D, Sadowska-Przytocka A, Wachal M, Adamski Z, Czarnecka-Operacz MM (2019) The role of Staphylococcus aureus in atopic dermatitis: microbiological and immunological implications. Postepy Dermatol Alergol 36:485. https:\/\/doi.org\/10.5114\/ada.2018.77056","journal-title":"Postepy Dermatol Alergol"},{"key":"18429_CR207","doi-asserted-by":"publisher","first-page":"606","DOI":"10.20344\/amp.11963","volume":"32","author":"T Torres","year":"2019","unstructured":"Torres T, Ferreira E, Gon\u00e7alo M, Mendes-Bastos P, Selores M, Filipe P (2019) Update on atopic dermatitis. Acta Med Port 32:606\u2013613. https:\/\/doi.org\/10.20344\/amp.11963","journal-title":"Acta Med Port"},{"key":"18429_CR208","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.16934","volume":"180","author":"T Tsakok","year":"2019","unstructured":"Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C (2019) Atopic dermatitis: the skin barrier and beyond. Br J Dermatol 180:464\u2013474. https:\/\/doi.org\/10.1111\/bjd.16934","journal-title":"Br J Dermatol"},{"key":"18429_CR209","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/acm.2018.0363","volume":"25","author":"AR Vaughn","year":"2019","unstructured":"Vaughn AR, Foolad N, Maarouf M, Tran KA, Shi VY (2019) Micronutrients in atopic dermatitis: a systematic review. J Altern Complement Med 25:567\u2013577. https:\/\/doi.org\/10.1089\/acm.2018.0363","journal-title":"J Altern Complement Med"},{"key":"18429_CR210","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1067\/mai.2003.101","volume":"111","author":"BA Von","year":"2003","unstructured":"Von BA, Koletzko S, Grubl A, Filipiak-Pittroff B, Wichmann HE, Bauer CP, Reinhardt D, Berdel D (2003) The effect of hydrolyzed cow\u2019s milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 111:533\u2013540. https:\/\/doi.org\/10.1067\/mai.2003.101","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR211","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jaci.2013.01.006","volume":"131","author":"BA Von","year":"2013","unstructured":"Von BA, Filipiak-Pittroff B, Kramer U, Hoffmann B, Link E, Beckmann C, Hoffmann U, Reinhardt D, Grubl A, Heinrich J, Wichmann HE, Bauer CP, Koletzko S, Berdel D (2013) Allergies in high-risk schoolchildren after early intervention with cow\u2019s milk protein hydrolysates: 10-year results from the German Infant Nutritional Intervention (GINI) study. J Allergy Clin Immunol 131:1565\u20131573. https:\/\/doi.org\/10.1016\/j.jaci.2013.01.006","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR212","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jaci.2008.04.021","volume":"121","author":"AB Von BergFilipiak-Pittroff","year":"2008","unstructured":"Von BergFilipiak-Pittroff AB, Kramer U, Link E, Bollrath C, Brockow I, Koletzko S, Grubl A, Heinrich J, Wichmann HE, Bauer CP, Reinhardt D, Berdel D (2008) Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 121:1442\u20131447. https:\/\/doi.org\/10.1016\/j.jaci.2008.04.021","journal-title":"J Allergy Clin Immunol"},{"key":"18429_CR213","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/iub.1405","volume":"67","author":"AX Wang","year":"2015","unstructured":"Wang AX, Xu LN (2015) New insights into T cells and their signature cytokines in atopic dermatitis. IUBMB Life 67:601\u2013610. https:\/\/doi.org\/10.1002\/iub.1405","journal-title":"IUBMB Life"},{"key":"18429_CR214","unstructured":"Wang, Chang Yi. (2020) Peptide immunogens Of IL-31 and formulations thereof for the treatment and\/or prevention of atopic dermatitis. IN202017024485."},{"key":"18429_CR215","unstructured":"Wang, Chang Yi. (2020) Peptide immunogens of IL-31 and formulations thereof for the treatment and\/or prevention of atopic dermatitis. SG11202005526W"},{"key":"18429_CR216","unstructured":"Wang, Chang Yi. (2020) Peptide immunogens of il-31 and formulations thereof for the treatment and\/or prevention of atopic dermatitis. CN111448208."},{"key":"18429_CR217","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1365-2222.2011.03946.x","volume":"42","author":"G Wegienka","year":"2012","unstructured":"Wegienka G, Havstad S, Joseph CL, Zoratti E, Ownby D, Woodcroft K, Johnson CC (2012) Racial disparities in allergic outcomes in African Americans emerge as early as age 2 years. Clin Exp Allergy 42:909\u2013917. https:\/\/doi.org\/10.1111\/j.1365-2222.2011.03946.x","journal-title":"Clin Exp Allergy"},{"key":"18429_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","volume":"4","author":"S Weidinger","year":"2018","unstructured":"Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD (2018) Atopic Dermatitis Nat Rev Dis Primers 4:1. https:\/\/doi.org\/10.1038\/s41572-018-0001-z","journal-title":"Atopic Dermatitis Nat Rev Dis Primers"},{"key":"18429_CR219","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1610-0387.2009.07141.x","volume":"7","author":"T Werfel","year":"2009","unstructured":"Werfel T (2009) Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy. J Dtsch Dermatol Ges 7:739\u2013742. https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07141.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"18429_CR220","unstructured":"Werfel T, Claes C, Kulp W, Greiner W, von der Schulenburg JM (2006) Therapy of atopic eczema. GMS Health Technol Assess 2: Doc19."},{"key":"18429_CR221","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1056\/NEJMcp042803","volume":"352","author":"HC Williams","year":"2005","unstructured":"Williams HC (2005) Atopic dermatitis. N Engl J Med 352:2314\u20132324. https:\/\/doi.org\/10.1056\/NEJMcp042803","journal-title":"N Engl J Med"},{"key":"18429_CR222","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2340\/00015555-3516","volume":"100","author":"HC Williams","year":"2020","unstructured":"Williams HC, Chalmers J (2020) Prevention of atopic dermatitis. Acta Derm Venereol 100:380\u2013388. https:\/\/doi.org\/10.2340\/00015555-3516","journal-title":"Acta Derm Venereol"},{"key":"18429_CR223","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.14888","volume":"32","author":"A Wollenberg","year":"2018","unstructured":"Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M (2018) Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 32:850\u2013878. https:\/\/doi.org\/10.1111\/jdv.14888","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"18429_CR224","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000211376","volume":"149","author":"K Yamaoka","year":"2009","unstructured":"Yamaoka K, Okayama Y, Kaminuma O, Katayama K, Mori A, Tatsumi H, Nemoto S, Hiroi T (2009) Proteomic approach to Fc\u03b5RI aggregation-initiated signal transduction cascade in human mast cells. Int Arch Allergy Immunol 149:73\u201376. https:\/\/doi.org\/10.1159\/000211376","journal-title":"Int Arch Allergy Immunol"},{"key":"18429_CR225","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamadermatol.2019.0008","volume":"155","author":"H Yang","year":"2019","unstructured":"Yang H, Wang J, Zhang X, Zhang Y, Qin ZL, Wang H, Luo XY (2019) Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol 155:585\u2013593. https:\/\/doi.org\/10.1001\/jamadermatol.2019.0008","journal-title":"JAMA Dermatol"},{"key":"18429_CR226","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3389\/fimmu.2020.01907","volume":"11","author":"L Yang","year":"2020","unstructured":"Yang L, Fu J, Zhou Y (2020) Research progress in atopic march. Front Immunol 11:1907. https:\/\/doi.org\/10.3389\/fimmu.2020.01907","journal-title":"Front Immunol"},{"key":"18429_CR227","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/IJN.S150319","volume":"13","author":"K Yu","year":"2018","unstructured":"Yu K, Wang Y, Wan T, Zhai Y, Cao S, Ruan W, Wu C, Xu Y (2018) Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. Int J Nanomedicine 13:129. https:\/\/doi.org\/10.2147\/IJN.S150319","journal-title":"Int J Nanomedicine"},{"key":"18429_CR228","doi-asserted-by":"publisher","first-page":"906","DOI":"10.2340\/00015555-2655","volume":"97","author":"M Zallmann","year":"2017","unstructured":"Zallmann M, Smith PK, Tang ML, Spelman LJ, Cahill JL, Wortmann G, Katelaris CH, Allen KJ, Su JC (2017) Debunking the myth of wool allergy: reviewing the evidence for immune and non-immune cutaneous reactions. Acta Derm Venereolo 97:906\u2013915. https:\/\/doi.org\/10.2340\/00015555-2655","journal-title":"Acta Derm Venereolo"},{"key":"18429_CR229","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.carbpol.2018.06.023","volume":"197","author":"F Zhuo","year":"2018","unstructured":"Zhuo F, Abourehab MA, Hussain Z (2018) Hyaluronic acid decorated tacrolimus-loaded nanoparticles: efficient approach to maximize dermal targeting and anti-dermatitis efficacy. Carbohydr Polym 197:478\u2013489. https:\/\/doi.org\/10.1016\/j.carbpol.2018.06.023","journal-title":"Carbohydr Polym"}],"container-title":["Environmental Science and Pollution Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-021-18429-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11356-021-18429-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11356-021-18429-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:10:01Z","timestamp":1684861801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11356-021-18429-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":229,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["18429"],"URL":"https:\/\/doi.org\/10.1007\/s11356-021-18429-8","relation":{},"ISSN":["0944-1344","1614-7499"],"issn-type":[{"value":"0944-1344","type":"print"},{"value":"1614-7499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors have approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}